Long-term effects of tumor necrosis factor-α treatment on indulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB
Tumor necrosis factor-alpha (TNF-alpha) mediated attenuation of insulin signaling pathway is an important cause in several disorders like obesity, obesity linked diabetes mellitus. TNF-a actions vary depending upon concentration and time of exposure in various cells. In the present study, the effects of long-term TNF-alpha (1 ng/ml) exposure on the components of insulin signaling pathway in HepG2 and HepG2 cells overexpressing constitutively active Akt1/PKB-alpha (HepG2-CA-Akt/PKB) have been investigated. In parental HepG2 cells, TNF-alpha treatment for 24 h reduced the phosphorylation of Akt1/PKB-alpha and GSK-3 beta and under these conditions cells also showed reduced insulin responsiveness in terms of Aktl/PKB-alpha and GSK-3 beta phosphorylation. TNF-alpha pre-incubated HepG2-CA-Akt/PKB cells showed lower reduction in Akt1/PKB-alpha and GSK-3 beta phosphorylation and insulin responsiveness after 24 h as compared to parental HepG2 cells. We report that the long-term TNF-a pre-incubation in both parental HepG2 and HepG2-CA-Akt/PKB-alpha cells leads to the reduction in the levels of IRS-1 without altering the levels of IRS-2. In order to understand the reason for the differential insulin resistance in both the cell types, the effect of long-term TNF-a treatment on the proteins upstream to Akt/PKB was investigated. TNF-a pre-incubation also showed reduced insulin-stimulated Tyr phosphorylation of insulin receptor (IR-beta) in both the cell types, moreover hyperphosphorylation of IRS-1 at Ser 312 residue was observed in TNF-alpha pre-incubated cells. As hyperphosphorylation of IRS-1 at Ser 312 can induce its degradation, it is possible that reduced insulin responsiveness after long-term TNF-alpha pre-incubation observed in this study is due to the decrease in IRS-1 levels.
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Aguirre, V
;
Werner, ED
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Werner, ED
;
论文数: 引用数:
h-index:
机构:
Giraud, J
;
Lee, YH
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Lee, YH
;
Shoelson, SE
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Shoelson, SE
;
White, MF
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Aguirre, V
;
Werner, ED
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Werner, ED
;
论文数: 引用数:
h-index:
机构:
Giraud, J
;
Lee, YH
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Lee, YH
;
Shoelson, SE
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA
Shoelson, SE
;
White, MF
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USAHarvard Univ, Howard Hughes Med Inst, Joslin Diabet Ctr, Sch Med, Boston, MA 02215 USA